glutamic acid and Muscular Weakness

glutamic acid has been researched along with Muscular Weakness in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's7 (87.50)29.6817
2010's1 (12.50)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Clarke, NF; Domazetovska, A; Kornberg, A; McLean, C; North, KN; Waddell, L1
Batish, SD; Biesecker, LG; Blouin, R; Brandt, C; Coppola, G; Ferguson, CJ; Grant, AE; Hoffman, S; Lenk, GM; Meisler, MH; Nicholson, G; Reddel, SW; Scheuerle, A; Simpson, E; Towne, CF; Yasick, M1
Cheema, SS; McQuilty, R; Pamphlett, R; Todd, E; Vink, R1
Schröder, JM; Sindern, E; Vorgerd, M; Züchner, S1
Förster, H; Huemer, M; Idriceanu, C; Kamper, A; Mayr, JA; Moslemi, AR; Muss, W; Oldfors, A; Sperl, W1
Benarroch, EE1
Bensimon, G; Dib, M; Lacomblez, L; Le Forestier, N; Marouan, A; Meininger, V; Pradat, PF; Salachas, F; Spreux-Varoquaux, O1
Alexander, GM; Deitch, JS; Del Valle, L; Heiman-Patterson, TD1

Reviews

1 review(s) available for glutamic acid and Muscular Weakness

ArticleYear
Brainstem respiratory control: substrates of respiratory failure of multiple system atrophy.
    Movement disorders : official journal of the Movement Disorder Society, 2007, Jan-15, Volume: 22, Issue:2

    Topics: Apnea; Brain Stem; Catecholamines; Glutamic Acid; Humans; Multiple System Atrophy; Muscle Weakness; Muscle, Skeletal; Neurons; Periodicity; Pons; Receptors, Neurokinin-1; Respiratory Insufficiency; Respiratory Physiological Phenomena; Respiratory Sounds; Serotonin; Solitary Nucleus

2007

Other Studies

7 other study(ies) available for glutamic acid and Muscular Weakness

ArticleYear
Cap disease due to mutation of the beta-tropomyosin gene (TPM2).
    Neuromuscular disorders : NMD, 2009, Volume: 19, Issue:5

    Topics: Adolescent; Amino Acid Sequence; Base Sequence; Cardiomyopathies; DNA Mutational Analysis; Female; Genetic Markers; Genetic Predisposition to Disease; Genotype; Glutamic Acid; Humans; Muscle Fibers, Skeletal; Muscle Weakness; Muscle, Skeletal; Muscular Diseases; Myocardium; Sarcomeres; Sequence Deletion; Tropomyosin

2009
Distinctive genetic and clinical features of CMT4J: a severe neuropathy caused by mutations in the PI(3,5)P₂ phosphatase FIG4.
    Brain : a journal of neurology, 2011, Volume: 134, Issue:Pt 7

    Topics: Adult; Australia; Charcot-Marie-Tooth Disease; Child; Child, Preschool; Exons; Family Health; Female; Flavoproteins; Foot Deformities; Genotype; Glutamic Acid; Humans; Lysine; Male; Middle Aged; Models, Molecular; Muscle Weakness; Mutation; Neural Conduction; Phenotype; Phosphoric Monoester Hydrolases; Sural Nerve

2011
Magnesium supplementation does not delay disease onset or increase survival in a mouse model of familial ALS.
    Journal of the neurological sciences, 2003, Dec-15, Volume: 216, Issue:1

    Topics: Age of Onset; Amyotrophic Lateral Sclerosis; Animals; Brain; Disease Models, Animal; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Glutamic Acid; Hand Strength; Magnesium; Mice; Mice, Transgenic; Muscle Weakness; Receptors, N-Methyl-D-Aspartate; Superoxide Dismutase; Superoxide Dismutase-1; Survival Rate; Treatment Failure

2003
The novel neurofilament light (NEFL) mutation Glu397Lys is associated with a clinically and morphologically heterogeneous type of Charcot-Marie-Tooth neuropathy.
    Neuromuscular disorders : NMD, 2004, Volume: 14, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Axons; Charcot-Marie-Tooth Disease; Deafness; DNA Mutational Analysis; Female; Genetic Testing; Glutamic Acid; Humans; Lysine; Male; Microscopy, Electron; Middle Aged; Muscle Weakness; Mutation; Neural Conduction; Neurofilament Proteins; Pedigree; Peripheral Nerves; Phenotype; Protein Structure, Tertiary; Sural Nerve

2004
A novel sporadic mutation G14739A of the mitochondrial tRNA(Glu) in a girl with exercise intolerance.
    Neuromuscular disorders : NMD, 2006, Volume: 16, Issue:12

    Topics: Brain; Child; DNA Mutational Analysis; Exercise Tolerance; Female; Genetic Predisposition to Disease; Glutamic Acid; Humans; Mitochondrial Diseases; Mitochondrial Myopathies; Muscle Fibers, Skeletal; Muscle Weakness; Muscle, Skeletal; Mutation; RNA; RNA, Mitochondrial; RNA, Transfer

2006
Glutamate levels in cerebrospinal fluid in amyotrophic lateral sclerosis: a reappraisal using a new HPLC method with coulometric detection in a large cohort of patients.
    Journal of the neurological sciences, 2002, Jan-15, Volume: 193, Issue:2

    Topics: Age Factors; Aged; Amyotrophic Lateral Sclerosis; Cerebrospinal Fluid; Chromatography, High Pressure Liquid; Cohort Studies; Colorimetry; Disease Progression; Female; Glutamic Acid; Humans; Male; Middle Aged; Muscle Weakness; Neurons; Paresis; Rhombencephalon; Sex Factors; Spinal Cord

2002
GLT-1 glutamate transporter levels are unchanged in mice expressing G93A human mutant SOD1.
    Journal of the neurological sciences, 2002, Jan-15, Volume: 193, Issue:2

    Topics: Aging; Amino Acid Transport System X-AG; Amyotrophic Lateral Sclerosis; Animals; Carrier Proteins; Central Nervous System; Dimerization; Disease Models, Animal; Electrophoresis, Polyacrylamide Gel; Excitatory Amino Acid Transporter 1; Excitatory Amino Acid Transporter 2; Excitatory Amino Acid Transporter 3; Female; Glutamate Plasma Membrane Transport Proteins; Glutamic Acid; Humans; Immunohistochemistry; Male; Mice; Mice, Transgenic; Molecular Weight; Motor Neurons; Muscle Weakness; Mutation; Phenotype; Superoxide Dismutase; Superoxide Dismutase-1; Symporters

2002